Geratherm Medical AG (ETR:GME)

Geratherm Medical AG Balance Sheet

Financials in millions EUR. Fiscal year is January - December.

Assets

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	7.61	7.68	5.24	8.74	2.26
Short-Term Investments	1.66	1.97	2.51	2.15	4.21
Cash & Short-Term Investments	9.26	9.64	7.74	10.89	6.47
Cash Growth	-3.94%	24.52%	-28.85%	68.25%	-36.95%
Accounts Receivable	1.26	1.19	1.81	3.78	3.18
Other Receivables	0.07	0.08	-	-	1.05
Receivables	1.33	1.27	1.81	3.78	4.23
Inventory	3.63	5.56	9.36	7.03	8.54
Other Current Assets	2.17	1.91	1.97	1.63	0.38
Total Current Assets	16.4	18.39	20.88	23.32	19.61
Property, Plant & Equipment	6.98	7.67	9.45	9.99	9.32
Long-Term Investments	0.73	0.73	0.63	0.63	1.37
Goodwill	-	-	0.07	0.08	0.09
Other Intangible Assets	1.73	1.61	4.56	4.04	1.07
Long-Term Deferred Charges	-	-	-	-	2.99
Other Long-Term Assets	0.15	0.14	0.13	0.33	0.1
Total Assets	26	28.54	35.72	38.38	34.56

Liabilities

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Accounts Payable	0.67	0.8	0.85	1.51	1.43
Accrued Expenses	1.54	1.01	2.46	2.45	1.68
Current Portion of Long-Term Debt	1.62	-	-	-	2.84
Current Portion of Leases	-	-	-	-	0.28
Current Income Taxes Payable	0	0.09	0.06	0.14	0.05
Current Unearned Revenue	-	-	-	-	1.76
Other Current Liabilities	0.4	0.18	0.13	0.22	0.39
Total Current Liabilities	4.23	2.08	3.5	4.31	8.43
Long-Term Debt	0.86	3.28	7.23	9.29	5.95
Long-Term Leases	-	-	-	-	0.25
Long-Term Unearned Revenue	0.79	0.9	1.43	1.52	1.29
Long-Term Deferred Tax Liabilities	0.12	0.18	0.03	0.03	0.01
Other Long-Term Liabilities	0.55	1.27	0.92	1	-
Total Liabilities	6.55	7.71	13.11	16.15	15.93

Shareholders' Equity

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Common Stock	5.41	5.41	5.41	5.44	4.95
Retained Earnings	-1.56	-0.2	-0.37	-0.66	-0.64
Comprehensive Income & Other	15.81	15.81	17.29	17.56	14.21
Total Common Equity	19.66	21.02	22.33	22.34	18.52
Minority Interest	-0.21	-0.2	0.28	-0.11	0.11
Shareholders' Equity	19.45	20.82	22.61	22.23	18.63
Total Liabilities & Equity	26	28.54	35.72	38.38	34.56

Additional Metrics

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Total Debt	2.48	3.28	7.23	9.29	9.32
Net Cash (Debt)	6.79	6.37	0.51	1.59	-2.85
Net Cash Growth	6.63%	1138.95%	-67.71%	-	-
Net Cash Per Share	1.25	1.18	0.09	0.29	-0.58
Filing Date Shares Outstanding	5.41	5.41	5.38	5.44	4.95
Total Common Shares Outstanding	5.41	5.41	5.38	5.44	4.95
Working Capital	12.17	16.31	17.38	19	11.18
Book Value Per Share	3.63	3.88	4.15	4.10	3.74
Tangible Book Value	17.93	19.41	17.7	18.21	17.36
Tangible Book Value Per Share	3.31	3.59	3.29	3.35	3.51
Land	7.09	7.09	7.33	7.33	7.35
Machinery	13.81	13.83	14.36	14.44	13.27
Construction In Progress	-	-	0.03	0.84	0.31
Order Backlog	-	-	-	-	0.08

Data Source: S&P Global Market Intelligence Last updated: Dec 31, 2025

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every six months for this company.

Update frequency:

Semi-annually

Last checked:

Aug 27, 2026

Data Sources Report a data error